// App-Quantinova.ai

13399 : Use of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) Venous Thromboembolism Risk Model and Elevated D-Dimer to Identify a High Venous Thromboembolism Risk in an Acutely Ill Medical Population for Extended Thromboprophylaxis

Researchers

Presenter

  • Alex C Spyropoulos

Principal Investigators

  • Gary Raskob

  • Theodore Spiro

  • Yoriko De Sanctis

  • Jianfeng Xu

  • Colleen Peluso

  • Elliot S Barnathan

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Enoxaparin

  • Enoxaparin sodium

Outcome

  • N/A


Study Design

  • Placebo Control

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A